• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

电抽搐治疗对难治性精神分裂症的疗效:一项双盲研究。

Efficacy of Electroconvulsive Therapy in Treatment Resistant Schizophreinia : A double-blind study.

机构信息

Unnati Kumar, MD, Senior Resident, Lady Hardinge Medical College & associated Hospitals, New Delhi 110001, INDIA.

出版信息

Indian J Psychiatry. 2003 Jan;45(1):26-9.

PMID:21206809
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2951535/
Abstract

BACKGROUND

ECT, though not favoured in the West for treating schizophrenia, is regularly practiced in India for this indication, particularly in poorly responding/treatment resistant cases.Therefore, its role in treatment-resistant schizophrenia is a subject of systematic investigation.

AIM

To compare the effectiveness and safety of Electroconvulsive therapy (ECT) in a group of treatment-resistant schizophrenia patients with a control group.

METHOD

Eligible and consenting patients were randomly allocated to the ECT or Sham ECT groups. Both received antipsychotic drugs.Twenty-five patients completed the study (ECT, n= IS; Sham ECT, n= 10).The study was conducted in a double-blind manner. Clinical change was assessed weekly with BPRS, CGI and adverse event measures.ANOVA for repeated measures and other post-hoc comparisons were used for data analysis.

RESULTS

ECT treated patients improved significantly over successive weeks (p< 0.002) after 6 ECTs, whereas the group receiving sham-ECT did not In both the groups, however, CGI scores did not change significantly, suggesting a dissociated response pattern. ECT was associated with greater relief among carers and lower rehospitalization.

CONCLUSION

ECT augmentation may well have a significant impact on the clinical course of patients with treatment resistance schizophrenia. It is unclear, but possible, that these changes may be reinforced and maintained by maintenance ECTs. Replication of the present investigation and further studies on maintenance ECT would be rewarding.

摘要

背景

尽管电抽搐疗法(ECT)在西方不常用于治疗精神分裂症,但在印度,它经常被用于这种适应症,特别是在反应不佳/治疗抵抗的病例中。因此,ECT 在治疗抵抗性精神分裂症中的作用是系统研究的主题。

目的

比较电抽搐疗法(ECT)在一组治疗抵抗性精神分裂症患者中的疗效和安全性与对照组。

方法

符合条件并同意的患者被随机分配到 ECT 或假 ECT 组。两组均接受抗精神病药物治疗。25 名患者完成了研究(ECT 组,n=13;假 ECT 组,n=10)。该研究采用双盲法进行。使用 BPRS、CGI 和不良反应措施每周评估临床变化。采用重复测量方差分析和其他事后比较进行数据分析。

结果

ECT 治疗组在接受 6 次 ECT 后,每周的临床改善明显(p<0.002),而接受假 ECT 组则没有。然而,在两组中,CGI 评分均无显著变化,提示存在分离反应模式。ECT 与照料者的更大缓解和较低的再住院率相关。

结论

ECT 增强可能对治疗抵抗性精神分裂症患者的临床病程产生重大影响。目前尚不清楚,但有可能,这些变化可能通过维持性 ECT 得到加强和维持。复制本研究和进一步的维持性 ECT 研究将是有益的。

相似文献

1
Efficacy of Electroconvulsive Therapy in Treatment Resistant Schizophreinia : A double-blind study.电抽搐治疗对难治性精神分裂症的疗效:一项双盲研究。
Indian J Psychiatry. 2003 Jan;45(1):26-9.
2
Augmentation of clozapine with ECT: a retrospective case analysis.氯氮平联合电抽搐治疗的增效作用:回顾性病例分析。
Acta Neuropsychiatr. 2021 Feb;33(1):31-36. doi: 10.1017/neu.2020.32. Epub 2020 Sep 24.
3
Clinical efficacy and neurobiological correlates of electroconvulsive therapy in patients with clozapine-resistant/intolerant schizophrenia: study protocol of multi-site parallel arm double-blind randomized sham-controlled study.氯氮平难治性/不耐受精神分裂症患者电休克治疗的临床疗效及神经生物学相关性:多中心平行组双盲随机假对照研究方案
Wellcome Open Res. 2022 Oct 5;7:212. doi: 10.12688/wellcomeopenres.18028.2. eCollection 2022.
4
Electroconvulsive therapy for schizophrenia.精神分裂症的电休克治疗
Cochrane Database Syst Rev. 2005 Apr 18(2):CD000076. doi: 10.1002/14651858.CD000076.pub2.
5
Double-blind randomized controlled study showing symptomatic and cognitive superiority of bifrontal over bitemporal electrode placement during electroconvulsive therapy for schizophrenia.双盲随机对照研究表明,在电抽搐治疗精神分裂症时,双额电极放置相对于双颞电极放置在症状和认知方面具有优越性。
Brain Stimul. 2013 Mar;6(2):210-7. doi: 10.1016/j.brs.2012.04.002. Epub 2012 Apr 23.
6
Efficacy of electroconvulsive therapy in treatment-resistant schizophrenia: a prospective open trial.电休克治疗难治性精神分裂症的疗效:一项前瞻性开放试验。
Prog Neuropsychopharmacol Biol Psychiatry. 2003 May;27(3):373-9. doi: 10.1016/S0278-5846(02)00354-8.
7
The clinical profile and outcome of patients receiving continuation electroconvulsive therapy (C-ECT): A retrospective study.接受延续性电休克治疗(C-ECT)患者的临床特征及结局:一项回顾性研究。
Indian J Psychiatry. 2023 Jun;65(6):647-654. doi: 10.4103/indianjpsychiatry.indianjpsychiatry_169_23. Epub 2023 Jun 19.
8
Electroconvulsive therapy for schizophrenia.精神分裂症的电休克治疗
Cochrane Database Syst Rev. 2002(2):CD000076. doi: 10.1002/14651858.CD000076.
9
Electroconvulsive therapy augmentation in clozapine-resistant schizophrenia: a prospective, randomized study.氯氮平抵抗性精神分裂症的电抽搐治疗增效:一项前瞻性、随机研究。
Am J Psychiatry. 2015 Jan;172(1):52-8. doi: 10.1176/appi.ajp.2014.13060787. Epub 2014 Oct 31.
10
A prospective multicenter assessor-blinded randomized controlled study to compare the efficacy of short versus long protocols of electroconvulsive therapy as an augmentation strategy to clozapine in patients with ultra-resistant schizophrenia (SURECT study).一项前瞻性、多中心、评估者设盲、随机对照研究,旨在比较电抽搐治疗的短程与长程方案作为增效策略,与氯氮平联合治疗超难治性精神分裂症的疗效(SURECT 研究)。
Trials. 2021 Apr 15;22(1):284. doi: 10.1186/s13063-021-05227-3.

引用本文的文献

1
Guideline for pharmacological treatment of schizophrenia 2022.《2022年精神分裂症药物治疗指南》
Neuropsychopharmacol Rep. 2025 Mar;45(1):e12497. doi: 10.1002/npr2.12497. Epub 2024 Nov 25.
2
Electroconvulsive therapy for the acute management of severe agitation in dementia (ECT-AD): A modified study protocol.电抽搐治疗用于痴呆严重激越的急性期管理(ECT-AD):改良研究方案。
PLoS One. 2024 Jun 28;19(6):e0303894. doi: 10.1371/journal.pone.0303894. eCollection 2024.
3
Clinical efficacy and neurobiological correlates of electroconvulsive therapy in patients with clozapine-resistant/intolerant schizophrenia: study protocol of multi-site parallel arm double-blind randomized sham-controlled study.氯氮平难治性/不耐受精神分裂症患者电休克治疗的临床疗效及神经生物学相关性:多中心平行组双盲随机假对照研究方案
Wellcome Open Res. 2022 Oct 5;7:212. doi: 10.12688/wellcomeopenres.18028.2. eCollection 2022.
4
Japanese Society of Neuropsychopharmacology: "Guideline for Pharmacological Therapy of Schizophrenia".日本神经精神药理学学会:《精神分裂症药物治疗指南》
Neuropsychopharmacol Rep. 2021 Sep;41(3):266-324. doi: 10.1002/npr2.12193. Epub 2021 Aug 12.
5
Electroconvulsive Therapy and Schizophrenia: A Systematic Review.电休克治疗与精神分裂症:一项系统综述
Mol Neuropsychiatry. 2019 Apr;5(2):75-83. doi: 10.1159/000497376. Epub 2019 Apr 2.
6
Electroconvulsive therapy for treatment-resistant schizophrenia.电休克治疗难治性精神分裂症
Cochrane Database Syst Rev. 2019 Mar 19;3(3):CD011847. doi: 10.1002/14651858.CD011847.pub2.
7
Treatment resistant schizophrenia: Clinical, biological, and therapeutic perspectives.治疗抵抗性精神分裂症:临床、生物学和治疗学视角。
Neurobiol Dis. 2019 Nov;131:104257. doi: 10.1016/j.nbd.2018.08.016. Epub 2018 Aug 29.
8
Combined use of electroconvulsive therapy and antipsychotics (both clozapine and non-clozapine) in treatment resistant schizophrenia: A comparative meta-analysis.电休克治疗与抗精神病药物(氯氮平和非氯氮平)联合用于难治性精神分裂症的治疗:一项比较性荟萃分析。
Heliyon. 2017 Nov 3;3(11):e00429. doi: 10.1016/j.heliyon.2017.e00429. eCollection 2017 Nov.
9
Impacts of Electroconvulsive Therapy on 1-Year Outcomes in Patients With Schizophrenia: A Controlled, Population-Based Mirror-Image Study.电抽搐治疗对精神分裂症患者 1 年结局的影响:一项对照、基于人群的镜像研究。
Schizophr Bull. 2018 Jun 6;44(4):798-806. doi: 10.1093/schbul/sbx136.
10
Electroconvulsive Therapy Added to Non-Clozapine Antipsychotic Medication for Treatment Resistant Schizophrenia: Meta-Analysis of Randomized Controlled Trials.电休克治疗联合非氯氮平抗精神病药物用于难治性精神分裂症的治疗:随机对照试验的荟萃分析
PLoS One. 2016 Jun 10;11(6):e0156510. doi: 10.1371/journal.pone.0156510. eCollection 2016.